JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPM Financial is issuing new securities, watch for details on terms and use of proceeds.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026. This filing is a pricing supplement, indicating the company is offering new securities under an existing registration statement (File No. 333-270004-01). For investors, this means JPMorgan Chase Financial Co. LLC is likely raising capital, which could be used for general corporate purposes, potentially impacting future earnings or debt levels of the parent company, JPMorgan Chase & Co.

Why It Matters

This filing signals JPMorgan Chase Financial Co. LLC is issuing new securities, which could dilute existing shareholders or increase the company's debt, impacting the financial health of its parent, JPMorgan Chase & Co.

Risk Assessment

Risk Level: medium — The filing itself is routine, but the underlying offering of new securities carries inherent market and financial risks for investors.

Analyst Insight

Investors should look for the full pricing supplement details to understand the terms of the new securities, including interest rates, maturity dates, and how the proceeds will be used, to assess potential impact on JPMorgan Chase & Co.'s financials.

Key Numbers

• 0001918704-26-007972 — SEC Accession No. (Unique identifier for this specific filing)
• 2026-03-24 — Filing Date (Date the 424B2 was filed with the SEC)
• 161664 — Size (bytes) (Size of the primary PRICING SUPPLEMENT document)
• 0001665650 — CIK (Central Index Key for JPMorgan Chase Financial Co. LLC)
• 0000019617 — CIK (Central Index Key for JPMORGAN CHASE & CO)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMORGAN CHASE & CO (company) — Parent company of the filer
• March 24, 2026 (date) — Filing date of the 424B2
• 333-270004-01 (dollar_amount) — File number for JPMorgan Chase Financial Co. LLC's registration statement
• 333-270004 (dollar_amount) — File number for JPMORGAN CHASE & CO's registration statement

Forward-Looking Statements

• JPMorgan Chase Financial Co. LLC will successfully raise capital through this offering. (JPMorgan Chase Financial Co. LLC) — high confidence, target: 2026-06-30

FAQ

Key Financial Figures

• $651,000 — l Company LLC Structured Investments $651,000 Review Notes Linked to the Least Perf
• $1,000 — ribed below. Minimum denominations of $1,000 and integral multiples thereof The no
• $9.2696 — roceeds to Issuer Per note $1,000 $9.2696 $990.7304 Total $651,000 $6,034
• $990.7304 — Issuer Per note $1,000 $9.2696 $990.7304 Total $651,000 $6,034.50 $644,9
• $6,034.50 — 9.2696 $990.7304 Total $651,000 $6,034.50 $644,965.50 (1) See "Supplemental U
• $644,965.50 — 0.7304 Total $651,000 $6,034.50 $644,965.50 (1) See "Supplemental Use of Proceeds
• $9.50 — commissions will vary and will be up to $9.50 per $1,000 principal amount note. See "
• $953.10 — en the terms of the notes were set, was $953.10 per $1,000 principal amount note. See "
• $165.00 — ew Date Call Premium Amount First $165.00 Second $330.00 Final $495.00
• $330.00 — ium Amount First $165.00 Second $330.00 Final $495.00 PS- 2 | Structured
• $495.00 — $165.00 Second $330.00 Final $495.00 PS- 2 | Structured Investments Revi
• $1,165.00 — automatically called Total Payment $1,165.00 (16.50% return) Because the closing l
• $1,495.00 — automatically called Total Payment $1,495.00 (49.50% return) Because the closing l
• $1,000.00 — ual to Barrier Amount Total Payment $1,000.00 (0.00% return) Because the notes have
• $500.00 — s than Barrier Amount Total Payment $500.00 (-50.00% return) Because the notes ha

Filing Documents

• form424b2.htm (424B2) — 158KB
• exfilingfees.htm (EX-FILING FEES) — 5KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 179KB
• image_007.jpg (GRAPHIC) — 136KB
• image_008.jpg (GRAPHIC) — 141KB
• image_003.gif (GRAPHIC) — 3KB
• image_004.gif (GRAPHIC) — 5KB
• image_005.gif (GRAPHIC) — 5KB
• 0001918704-26-007972.txt ( ) — 932KB
• exfilingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $651,000 Review Notes Linked to the Least Performing of the Dow Jones Industrial Average , the Nasdaq-100 Index and the Russell 2000 Index due March 23, 2029 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek early exit prior to maturity at a premium if, on any Review Date, the closing level of each of the Dow Jones Industrial Average , the Nasdaq-100 Index and the Russell 2000 Index, which we refer to as the Indices, is at or above its Call Value. The earliest date on which an automatic call may be initiated is March 24, 2027. Investors should be willing to forgo interest and dividend payments and be willing to accept the risk of losing some or all of their principal amount at maturity. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Payments on the notes are not linked to a basket composed of the Indices. Payments on the notes are linked to the performance of each of the Indices individually, as described below. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660R4P6 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS-4 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $9.2696 $990.7304 Total $651,000 $6,034.50 $644,965.50 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to other affiliated or unaffiliated dealers. These selling commissions will vary and will be up to $9.50 per $1,000 principal amount note. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $953.10 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 1-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Indices: The Dow Jones Industrial Average (Bloomberg ticker: INDU), the Nasdaq-100 Index (Bloomberg ticker: NDX) and the Russell 2000 Index (Bloomberg ticker: RTY) (each an "Index" and collectively, the "Indices") Call Premium Amount: The Call Premium Amount with respect to each Review Date is set forth below: first Review Date: 16.50% $1,000 second Review Date: 33.00% $1,000 final Review Date: 49.50% $1,000 Call Value: With respect to each Index, 100.00% of its Initial Value Barrier Amount: With respect to each Index, 70.00% of its Initial Value, which is 31,904.229 for the Dow Jones Industrial Average , 16,728.705 for the Nasdaq-100 Index and 1,706.9157 for the Russell 2000 Index Pricing Date: March 20, 2026 Original Issue Date (Settlement Date): On or about March 25, 2026 Review Dates*: March 24, 2027, March 20, 2028 and March 20, 2029 (final Review Date) Call Settlement Dates*: March 29, 2027, March 23, 2028 and the Maturity Date Maturity Date*: March 23, 2029 * Subject to postponement in the event of a market disruption event and a

View Full Filing

View this 424B2 filing on SEC EDGAR